List of Tables
    Table 1. HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. HIV Integrase Strand Transfer Inhibitors (INSTI) Market Trends
    Table 3. HIV Integrase Strand Transfer Inhibitors (INSTI) Market Drivers
    Table 4. HIV Integrase Strand Transfer Inhibitors (INSTI) Market Challenges
    Table 5. HIV Integrase Strand Transfer Inhibitors (INSTI) Market Restraints
    Table 6. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top HIV Integrase Strand Transfer Inhibitors (INSTI) Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Share by Player, 2017-2022
    Table 13. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global HIV Integrase Strand Transfer Inhibitors (INSTI) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) as of 2021)
    Table 15. Top Players of HIV Integrase Strand Transfer Inhibitors (INSTI) in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into HIV Integrase Strand Transfer Inhibitors (INSTI) Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top HIV Integrase Strand Transfer Inhibitors (INSTI) Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America HIV Integrase Strand Transfer Inhibitors (INSTI) Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa HIV Integrase Strand Transfer Inhibitors (INSTI) Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Adcock Ingram Limited Company Details
    Table 31. Adcock Ingram Limited Business Overview
    Table 32. Adcock Ingram Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Product
    Table 33. Adcock Ingram Limited Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2017-2022) & (US$ Million)
    Table 34. Adcock Ingram Limited Recent Development
    Table 35. Affine Formulations Limited Company Details
    Table 36. Affine Formulations Limited Business Overview
    Table 37. Affine Formulations Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Product
    Table 38. Affine Formulations Limited Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2017-2022) & (US$ Million)
    Table 39. Affine Formulations Limited Recent Development
    Table 40. Aurobindo Pharma Company Details
    Table 41. Aurobindo Pharma Business Overview
    Table 42. Aurobindo Pharma HIV Integrase Strand Transfer Inhibitors (INSTI) Product
    Table 43. Aurobindo Pharma Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2017-2022) & (US$ Million)
    Table 44. Aurobindo Pharma Recent Development
    Table 45. Biocon Limited Company Details
    Table 46. Biocon Limited Business Overview
    Table 47. Biocon Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Product
    Table 48. Biocon Limited Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2017-2022) & (US$ Million)
    Table 49. Biocon Limited Recent Development
    Table 50. Bristol-Myers Squibb Company Details
    Table 51. Bristol-Myers Squibb Business Overview
    Table 52. Bristol-Myers Squibb HIV Integrase Strand Transfer Inhibitors (INSTI) Product
    Table 53. Bristol-Myers Squibb Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2017-2022) & (US$ Million)
    Table 54. Bristol-Myers Squibb Recent Development
    Table 55. Cipla Company Details
    Table 56. Cipla Business Overview
    Table 57. Cipla HIV Integrase Strand Transfer Inhibitors (INSTI) Product
    Table 58. Cipla Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2017-2022) & (US$ Million)
    Table 59. Cipla Recent Development
    Table 60. Emcure Pharmaceuticals Company Details
    Table 61. Emcure Pharmaceuticals Business Overview
    Table 62. Emcure Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Product
    Table 63. Emcure Pharmaceuticals Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2017-2022) & (US$ Million)
    Table 64. Emcure Pharmaceuticals Recent Development
    Table 65. Flamingo Pharmaceuticals Limited Company Details
    Table 66. Flamingo Pharmaceuticals Limited Business Overview
    Table 67. Flamingo Pharmaceuticals Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Product
    Table 68. Flamingo Pharmaceuticals Limited Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2017-2022) & (US$ Million)
    Table 69. Flamingo Pharmaceuticals Limited Recent Development
    Table 70. Gilead Sciences Company Details
    Table 71. Gilead Sciences Business Overview
    Table 72. Gilead Sciences HIV Integrase Strand Transfer Inhibitors (INSTI) Product
    Table 73. Gilead Sciences Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2017-2022) & (US$ Million)
    Table 74. Gilead Sciences Recent Development
    Table 75. Hetero Drugs Company Details
    Table 76. Hetero Drugs Business Overview
    Table 77. Hetero Drugs HIV Integrase Strand Transfer Inhibitors (INSTI) Product
    Table 78. Hetero Drugs Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2017-2022) & (US$ Million)
    Table 79. Hetero Drugs Recent Development
    Table 80. IPCA Laboratories Company Details
    Table 81. IPCA Laboratories Business Overview
    Table 82. IPCA Laboratories HIV Integrase Strand Transfer Inhibitors (INSTI) Product
    Table 83. IPCA Laboratories Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2017-2022) & (US$ Million)
    Table 84. IPCA Laboratories Recent Development
    Table 85. Janssen Pharmaceutica (Johnson & Johnson) Company Details
    Table 86. Janssen Pharmaceutica (Johnson & Johnson) Business Overview
    Table 87. Janssen Pharmaceutica (Johnson & Johnson) HIV Integrase Strand Transfer Inhibitors (INSTI) Product
    Table 88. Janssen Pharmaceutica (Johnson & Johnson) Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2017-2022) & (US$ Million)
    Table 89. Janssen Pharmaceutica (Johnson & Johnson) Recent Development
    Table 90. LAURUS Labs Company Details
    Table 91. LAURUS Labs Business Overview
    Table 92. LAURUS Labs HIV Integrase Strand Transfer Inhibitors (INSTI) Product
    Table 93. LAURUS Labs Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2017-2022) & (US$ Million)
    Table 94. LAURUS Labs Recent Development
    Table 95. Medisist Pharma Company Details
    Table 96. Medisist Pharma Business Overview
    Table 97. Medisist Pharma HIV Integrase Strand Transfer Inhibitors (INSTI) Product
    Table 98. Medisist Pharma Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2017-2022) & (US$ Million)
    Table 99. Medisist Pharma Recent Development
    Table 100. Merck Company Details
    Table 101. Merck Business Overview
    Table 102. Merck HIV Integrase Strand Transfer Inhibitors (INSTI) Product
    Table 103. Merck Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2017-2022) & (US$ Million)
    Table 104. Merck Recent Development
    Table 105. Mylan Company Details
    Table 106. Mylan Business Overview
    Table 107. Mylan HIV Integrase Strand Transfer Inhibitors (INSTI) Product
    Table 108. Mylan Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2017-2022) & (US$ Million)
    Table 109. Mylan Recent Development
    Table 110. Ranbaxy Pharmaceuticals Company Details
    Table 111. Ranbaxy Pharmaceuticals Business Overview
    Table 112. Ranbaxy Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Product
    Table 113. Ranbaxy Pharmaceuticals Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2017-2022) & (US$ Million)
    Table 114. Ranbaxy Pharmaceuticals Recent Development
    Table 115. Shanghai Desano Pharmaceuticals Company Details
    Table 116. Shanghai Desano Pharmaceuticals Business Overview
    Table 117. Shanghai Desano Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Product
    Table 118. Shanghai Desano Pharmaceuticals Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2017-2022) & (US$ Million)
    Table 119. Shanghai Desano Pharmaceuticals Recent Development
    Table 120. ViiV Healthcare (GSK) Company Details
    Table 121. ViiV Healthcare (GSK) Business Overview
    Table 122. ViiV Healthcare (GSK) HIV Integrase Strand Transfer Inhibitors (INSTI) Product
    Table 123. ViiV Healthcare (GSK) Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2017-2022) & (US$ Million)
    Table 124. ViiV Healthcare (GSK) Recent Development
    Table 125. Research Programs/Design for This Report
    Table 126. Key Data Information from Secondary Sources
    Table 127. Key Data Information from Primary Sources
List of Figures
    Figure 1. HIV Integrase Strand Transfer Inhibitors (INSTI) Product Picture
    Figure 2. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size 2017-2028 (US$ Million)
    Figure 4. United States HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size 2017-2028 (US$ Million)
    Figure 6. United States HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share in Global 2017-2028
    Figure 7. HIV Integrase Strand Transfer Inhibitors (INSTI) Report Years Considered
    Figure 8. Product Picture of Raltegravir
    Figure 9. Product Picture of Elvitegravir Combination Drugs
    Figure 10. Product Picture of Dolutegravir and Its Combination Drug
    Figure 11. Product Picture of Bictegravir Combination Drug
    Figure 12. Product Picture of Cabotegravir
    Figure 13. Product Picture of Other
    Figure 14. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Type in 2022 & 2028
    Figure 15. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2017-2028) & (US$ Million)
    Figure 16. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Type (2017-2028)
    Figure 17. United States HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Type in 2022 & 2028
    Figure 18. United States HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2017-2028) & (US$ Million)
    Figure 19. United States HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Type (2017-2028)
    Figure 20. Product Picture of Hospital
    Figure 21. Product Picture of Clinic
    Figure 22. Product Picture of Drug Center
    Figure 23. Product Picture of Other
    Figure 24. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Application in 2022 & 2028
    Figure 25. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2017-2028) & (US$ Million)
    Figure 26. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Application (2017-2028)
    Figure 27. United States HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Application in 2022 & 2028
    Figure 28. United States HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2017-2028) & (US$ Million)
    Figure 29. United States HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Application (2017-2028)
    Figure 30. North America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 31. U.S. HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. Canada HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 34. Germany HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. France HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. U.K. HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. Italy HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. Russia HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. Asia-Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 40. China HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. Japan HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. South Korea HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. India HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Australia HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Taiwan HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Indonesia HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Thailand HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Malaysia HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Philippines HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Latin America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 51. Mexico HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Brazil HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Argentina HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 55. Turkey HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 56. Saudi Arabia HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 57. U.A.E HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Adcock Ingram Limited Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2017-2022)
    Figure 59. Affine Formulations Limited Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2017-2022)
    Figure 60. Aurobindo Pharma Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2017-2022)
    Figure 61. Biocon Limited Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2017-2022)
    Figure 62. Bristol-Myers Squibb Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2017-2022)
    Figure 63. Cipla Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2017-2022)
    Figure 64. Emcure Pharmaceuticals Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2017-2022)
    Figure 65. Flamingo Pharmaceuticals Limited Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2017-2022)
    Figure 66. Gilead Sciences Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2017-2022)
    Figure 67. Hetero Drugs Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2017-2022)
    Figure 68. IPCA Laboratories Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2017-2022)
    Figure 69. Janssen Pharmaceutica (Johnson & Johnson) Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2017-2022)
    Figure 70. LAURUS Labs Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2017-2022)
    Figure 71. Medisist Pharma Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2017-2022)
    Figure 72. Merck Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2017-2022)
    Figure 73. Mylan Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2017-2022)
    Figure 74. Ranbaxy Pharmaceuticals Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2017-2022)
    Figure 75. Shanghai Desano Pharmaceuticals Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2017-2022)
    Figure 76. ViiV Healthcare (GSK) Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2017-2022)
    Figure 77. Bottom-up and Top-down Approaches for This Report
    Figure 78. Data Triangulation
    Figure 79. Key Executives Interviewed